Training.

By using Pharmora, none of the clients time is wasted up-skilling our staff. We are able to provide medics and scientists with the qualifiactions and skills necessary to carry out the required service. Any general training will be provided by us.

Not only are we upskilling our staff, but we also offer engaging training days, as described by our team below.

Our cascade learning approach

Each time we provide our services, our clients benefit from the wealth of expertise within Pharmora, and not just from the skill and experience of the individual(s) nominated to provide that service.

Senior medics and scientists support and train less experienced Medical Department staff who are assigned to client deliverables. This means that we can offer a competitive rate for a high quality level of service, including input and oversight from the more experienced members of our team.

Masterclass – the series

Our CMO and other talented members of our team have written what we like to call ‘Masterclasses’ covering an incredibly wide range of topics from Immunisation all the way UMR (Unblinded Medical Review). Click one of the examples to read more.

Medical Monitoring Masterclass: Where Safety Meets Scientific Rigour

The fifth and final instalment of our Medical Monitoring Masterclass, we’re focussing on medical monitoring in generics development.

Medical Monitoring Masterclass: Medical Monitoring in Biosimilar Development

In the fourth instalment of our Medical Monitoring Masterclass to celebrate Clinical Trials Day 2026, we’re looking at why biosimilar trials require specialist monitoring along with immunogenicity – one of the most important considerations in biosimilar development.

Medical Monitoring Masterclass: Building a Trial That Investors Will Believe In

In the second instalment of our Medical Monitoring Masterclass to celebrate Clinical Trials Day 2026, we’ve written a guide on medical monitoring for biotechs with some insights into why clinical trials are crucial.

Medical Monitoring Masterclass: What Quality Oversight Means for Your Asset

In the third instalment of our Medical Monitoring Masterclass to celebrate Clinical Trials Day 2026, we’re looking at clinical risk and what quality oversight means for your asset.

Medical Monitoring Masterclass: What Is It and Why Does It Matter?

In celebration of Clinical Trials Day 2026, we have created a Medical Monitoring Masterclass. In this first instalment, we discuss the importance of medical monitoring and the changing regulatory landscape.

Ovarian Cancer (3 of 3): Treatments

In the final instalment of this masterclass, we explore current available treatment options and the treatments that are in development in both the laboratory and clinical trial stages.

Ovarian Cancer (2 of 3): Types & Statistics

In the second instalment of this masterclass, we discuss the wide variety of types and sub-types of ovarian cancer including the variations in symptoms and survival rates.

Ovarian Cancer (1 of 3): Signs & Symptoms

In the first instalment of this masterclass, we discuss the signs and symptoms that indicate ovarian cancer, along with the importance of bringing these symptoms to a healthcare professional as early as possible.

Current and future treatments for HIV/AIDS, Medical Information (3 of 3)

In this 3rd and final blog of the series, Josh describes the current management of HIV/AIDS, discusses the medicines in development, and provides an insight into the health inequality impacting this condition.

Early treatments, the Stigma and HAART, Medical Information (2 of 3)

In our previous blog, we looked at the initial discovery of HIV, the mechanisms of how it infects CD4 cells and the human cost of the virus in the 1980s. Here, we will discuss the first treatments to become available for HIV, their side effects, the stigma associated with the disease and what that meant for patient prognosis, and the introduction of Highly Active Antiretroviral Therapy (HAART).

Hear from our team!